| ID Source | ID |
|---|---|
| PubMed CID | 568919 |
| MeSH ID | M0154070 |
| Synonym |
|---|
| 1,3-dioxane, 2,4,6-triphenyl- |
| 2,4,6-triphenyldioxane-1,3 |
| 2,4,6-triphenyl-1,3-dioxane |
| 117525-88-9 |
| JISOWUQFKXKMNL-UHFFFAOYSA-N |
| DTXSID60922456 |
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dose-response studies have shown that cisTPD, transpDMA, transpF and transpNO(2) have similar potency, and transTPD is less potent derivative." | ( Effect of several analogs of 2,4,6-triphenyldioxane-1,3 on constitutive androstane receptor activation. Gulyaeva, L; Kachaylo, E; Lyakhovich, V; Pustylnyak, V; Slynko, N; Yarushkin, A, 2011) | 0.37 |
| " To further characterize the compounds, we determined ED50s using sigmoidal dose-response curves." | ( Effect of several analogs of 2,4,6-triphenyldioxane-1,3 on CYP2B induction in mouse liver. Gulyaeva, L; Kazakova, Y; Pustylnyak, V; Slynko, N; Yarushkin, A, 2011) | 0.37 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.31) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 12 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||